Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital (iCor) have found beneficial ...
May 14, 2024
0
0
As many patients already know, urinary tract infections (UTIs) can recur despite the use of antibiotics.
Apr 25, 2024
0
4
Attention-Deficit Hyperactivity Disorder (ADHD) is the most common pediatric neurobehavioral disorder, with a prevalence of approximately 7%–10% in school-age children. ADHD significantly affects functioning throughout ...
Apr 1, 2024
0
0
If Australia wants better results from its annual $180 billion dollars health care services expenditure, health economists must play a key role in decision-making to improve the efficiency of local hospitals and health networks.
Feb 29, 2024
0
0
A research team from Tohoku University Graduate School of Medicine undertook a detailed examination of the medical validity of deep learning models using post-mortem imaging for diagnosing drowning. The results reveal an ...
Feb 27, 2024
0
0
Surgeons who routinely change surgical gloves and instruments are incurring similar costs to those using the same equipment, a new study has found.
Feb 14, 2024
0
32
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center.
Feb 14, 2024
0
19
Vending machines dispensing self-test kits for sexually transmitted infections (STIs) are an effective and acceptable means of reaching people who rarely or never get tested, find the results of a year-long pilot, published ...
Feb 2, 2024
0
20
A spike in the use of ADHD medications during the pandemic likely prompted drug shortages that continue to frustrate patients and doctors today, a new study shows.
Jan 11, 2024
0
0
The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.
Aug 27, 2023
0
2
